kpcczКомплексные проблемы сердечно-сосудистых заболеванийComplex Issues of Cardiovascular Diseases2306-12782587-9537Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”10.17802/2306-1278-2024-13-3S-151-161kpccz-1501Research ArticleАНАЛИТИЧЕСКИЙ ОБЗОР. Сердечно-сосудистая хирургия. Патологическая физиологияREVIEW. Cardiovascular Surgery. Pathological PhysiologyПЕРСПЕКТИВА ПРИМЕНЕНИЯ КОНЦЕПЦИИ МОРФОФУНКЦИОНАЛЬНОЙ СИСТЕМЫ «КОНДУИТ – АРТЕРИЯ» ПРИ ВЗАИМОДЕЙСТВИИ КОРОНАРНОЙ АРТЕРИИ СО СТЕНТОМ/БАЛЛОНОМPERSPECTIVE ON THE MORPHOFUNCTIONAL ARTERIAL CONDUIT SYSTEM CONCEPT USE IN INTERACTION BETWEEN CORONARY ARTERY AND STENT/BALLONhttps://orcid.org/0000-0002-1746-8895ФроловАлексей ВитальевичFrolovAlexey V.

доктор медицинских наук, старший научный сотрудник лаборатории рентгенэндоваскулярной и реконструктивной хирургии сердца и сосудов отдела хирургии сердца и сосудов федерального государственного бюджетного научного учреждения «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний» Кемерово, Российская Федерация

MD, PhD, Senior Researcher at the Laboratory for Image-guided Endovascular and Reconstructive Cardiovascular Surgery, Department of Cardiovascular Surgery, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation

kjerne@yandex.ruФедеральное государственное бюджетное научное учреждение «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний»РоссияFederal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”Russian Federation202401112024133Sприложение151161Copyright © Фролов А.В., 20242024Фролов А.В.Frolov A.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.nii-kpssz.com/jour/article/view/1501Основные положения

Основные положения

 

 

Резюме

Резюме

В обзорной статье приводится потенциальное моделирование взаимодействия стента/баллона с коронарной артерией по аналогии и на основе ранее предложенной концепции морфофункциональной системы «кондуит – артерия», которая обосновывает преимущества и недостатки различных вариантов коронарного шунтирования и имеет важное прикладное значение при выборе трансплантата. Указанное взаимодействие при проведении эндоваскулярного лечения ишемической болезни сердца играет важную роль в разработке нового поколения устройств, а также в управлении различными факторами, участвующими в профилактике дисфункции стента и прогрессирования коронарного атеросклероза.

Highlights

Highlights

 

 

Abstract

Abstract

 The review article describes potential modeling of the interaction between a stent/balloon and a coronary artery analogous to and based on the previously proposed concept of the morphofunctional arterial conduit system. The system substantiates the advantages and disadvantages of various techniques of coronary artery bypass grafting and should be accounted for when choosing a stent. This interaction during endovascular treatment of coronary artery disease is of great importance for the development of new generation of devices, as well as for the management of various factors involved in the prevention of stent dysfunction and progression of coronary atherosclerosis.

Морфофункциональная системаСтентыМоделированиеРеваскуляризация миокардаАтеросклерозMorphofunctional systemStentsModelingMyocardial revascularizationAtherosclerosisРаботы выполнена в рамках фундаментальной темы НИИ КПССЗ № 0419-2022-0002 «Разработка инновационных моделей управления риском развития болезней системы кровообращения с учетом коморбидности на основе изучения фундаментальных, клинических, эпидемиологических механизмов и организационных технологий медицинской помощи в условиях промышленного региона Сибири (научный руководитель – академик РАН О.Л. Барбараш)».ReferencesФролов А.В. Морфофункциональная система «кондуит-артерия». Комплексные проблемы сердечно-сосудистых заболеваний. 2019:8 (1): 112-122. doi: 10.17802/2306-1278-2019-8-1-112-122Frolov A.V. Morphological and functional system of graft-artery junctions. Complex Issues of Cardiovascular Diseases. 2019;8(1):112-122. doi: 10.17802/2306-1278-2019-8-1-112-122 (In Russian)Ahadi F., Azadi M., Biglari M., Bodaghi M., Khaleghian A. Evaluation of coronary stents: A review of types, materials, processing techniques, design, and problems. Heliyon. 2023:9(2):e13575. doi: 10.1016/j.heliyon.2023.e13575Ahadi F., Azadi M., Biglari M., Bodaghi M., Khaleghian A. Evaluation of coronary stents: A review of types, materials, processing techniques, design, and problems. Heliyon. 2023:9(2):e13575. doi: 10.1016/j.heliyon.2023.e13575Piccolo R., Bonaa K.H., Efthimiou O., Varenne O., Baldo A., Urban P., Kaiser C., Remkes W., Räber L., de Belder A., van ’t Hof A.W.J., Stankovic G., Lemos P.A., Wilsgaard T., Reifart J., Rodriguez A.E., Ribeiro E.E., Serruys P.W.J.C., Abizaid A., Sabaté M., Byrne R.A., de la Torre Hernandez J.M., Wijns W., Jüni P., Windecker S., Valgimigli M. Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet. 2019:393: 2503-10. doi: 10.1016/S0140-6736(19)30474-XPiccolo R., Bonaa K.H., Efthimiou O., Varenne O., Baldo A., Urban P., Kaiser C., Remkes W., Räber L., de Belder A., van ’t Hof A.W.J., Stankovic G., Lemos P.A., Wilsgaard T., Reifart J., Rodriguez A.E., Ribeiro E.E., Serruys P.W.J.C., Abizaid A., Sabaté M., Byrne R.A., de la Torre Hernandez J.M., Wijns W., Jüni P., Windecker S., Valgimigli M. Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet. 2019:393: 2503-10. doi: 10.1016/S0140-6736(19)30474-XJackson-Smith E., Zioupos S., Banerjee P. Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: a meta-analysis of randomised controlled trials. Open Heart. 2022:9:e002107. doi:10.1136/openhrt-2022-002107Jackson-Smith E., Zioupos S., Banerjee P. Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: a meta-analysis of randomised controlled trials. Open Heart. 2022:9:e002107. doi:10.1136/openhrt-2022-002107Lawton J.S., Tamis-Holland J.E., Bangalore S., Bates E.R., Beckie T.M., Bischoff J.M., Bittl J.A., Cohen M.G., DiMaio J.M., Don C.W., Fremes S.E., Gaudino M.F., Goldberger Z.D., Grant M.C., Jaswal J.B., Kurlansky P.A., Mehran R., Metkus T.S. Jr., Nnacheta L.C., Rao S.V., Sellke F.W., Sharma G., Yong C.M., Zwischenberger B.A. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022:18;145(3):e4-e17. doi: 10.1161/CIR.0000000000001039Lawton J.S., Tamis-Holland J.E., Bangalore S., Bates E.R., Beckie T.M., Bischoff J.M., Bittl J.A., Cohen M.G., DiMaio J.M., Don C.W., Fremes S.E., Gaudino M.F., Goldberger Z.D., Grant M.C., Jaswal J.B., Kurlansky P.A., Mehran R., Metkus T.S. Jr., Nnacheta L.C., Rao S.V., Sellke F.W., Sharma G., Yong C.M., Zwischenberger B.A. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022:18;145(3):e4-e17. doi: 10.1161/CIR.0000000000001039Pelliccia F., Zimarino M., Niccoli G., Morrone D., De Luca G., Miraldi F., De Caterina R. In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways. Eur Heart J Open. 2023 Aug 24;3(5):oead083. doi: 10.1093/ehjopen/oead083Pelliccia F., Zimarino M., Niccoli G., Morrone D., De Luca G., Miraldi F., De Caterina R. In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways. Eur Heart J Open. 2023 Aug 24;3(5):oead083. doi: 10.1093/ehjopen/oead083Paramasivam G., Devasia T., Ubaid S., Shetty A., Nayak K., Pai U., Rao M.S. In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario. The Egyptian Heart Journal. 2019:71:28. doi: 10.1186/s43044-019-0025-zParamasivam G., Devasia T., Ubaid S., Shetty A., Nayak K., Pai U., Rao M.S. In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario. The Egyptian Heart Journal. 2019:71:28. doi: 10.1186/s43044-019-0025-zCondello F., Spaccarotella C., Sorrentino S., Indolfi C., Stefanini G.G., Polimeni A. Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence. J. Clin. Med. 2023:12:1238. doi: 10.3390/jcm12031238Condello F., Spaccarotella C., Sorrentino S., Indolfi C., Stefanini G.G., Polimeni A. Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence. J. Clin. Med. 2023:12:1238. doi: 10.3390/jcm12031238Chacko L., Howard J.P., Rajkumar C., Nowbar A.N., Kane C., Mahdi D., Foley M., Shun-Shin M., Cole G., Sen S., Al-Lamee R., Francis D.P., Ahmad Y. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease A Meta-Analysis of Randomized Controlled Trials. Circ Cardiovasc Qual Outcomes. 2020;13:e006363. doi: 10.1161/CIRCOUTCOMES.119.006363Chacko L., Howard J.P., Rajkumar C., Nowbar A.N., Kane C., Mahdi D., Foley M., Shun-Shin M., Cole G., Sen S., Al-Lamee R., Francis D.P., Ahmad Y. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease A Meta-Analysis of Randomized Controlled Trials. Circ Cardiovasc Qual Outcomes. 2020;13:e006363. doi: 10.1161/CIRCOUTCOMES.119.006363Saito Y., Oyama K., Tsujita K., Yasuda S., Kobayashi Y. Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond. Journal of Cardiology. 2023:168-178. doi: 10.1016/j.jjcc.2022.07.003Saito Y., Oyama K., Tsujita K., Yasuda S., Kobayashi Y. Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond. Journal of Cardiology. 2023:168-178. doi: 10.1016/j.jjcc.2022.07.003Piccolo R., Bonaa K.H., Efthimiou O., Varenne O., Urban P., Kaiser C., Räber L., de Belder A., Remkes W., van’t Hof A.W.J., Stankovic G., Lemos P.A., Wilsgaard T., Reifart J., Rodriguez A.E., Ribeiro E.E., Serruys P.W.J.C., Abizaid A., Sabaté M., Byrne R.A., de la Torre Hernandez J.M., Wijns W., Esposito G., Jüni P., Windecker S., Valgimigli M. Drug-Eluting or Bare-Metal Stents for Left Anterior Descending or Left Main Coronary Artery Revascularization. J Am Heart Assoc. 2021:10:e018828. doi: 10.1161/JAHA.120.018828Piccolo R., Bonaa K.H., Efthimiou O., Varenne O., Urban P., Kaiser C., Räber L., de Belder A., Remkes W., van’t Hof A.W.J., Stankovic G., Lemos P.A., Wilsgaard T., Reifart J., Rodriguez A.E., Ribeiro E.E., Serruys P.W.J.C., Abizaid A., Sabaté M., Byrne R.A., de la Torre Hernandez J.M., Wijns W., Esposito G., Jüni P., Windecker S., Valgimigli M. Drug-Eluting or Bare-Metal Stents for Left Anterior Descending or Left Main Coronary Artery Revascularization. J Am Heart Assoc. 2021:10:e018828. doi: 10.1161/JAHA.120.018828Yamada K., Mizutani Y., Nakamura H., Ukaji T., Sato H., Koshikawa Y., Hori Y., Itabashi Y., Nakahara S., Ishikawa T., Kobayashi S., Taguchi I. Reperfusion Injury after Acute Myocardial Infarction. Dokkyo Medical Journal 2022:1(4): 274-284. doi: 10.51040/dkmj.2022-028Yamada K., Mizutani Y., Nakamura H., Ukaji T., Sato H., Koshikawa Y., Hori Y., Itabashi Y., Nakahara S., Ishikawa T., Kobayashi S., Taguchi I. Reperfusion Injury after Acute Myocardial Infarction. Dokkyo Medical Journal 2022:1(4): 274-284. doi: 10.51040/dkmj.2022-028Bytyçi I., Morina D., Bytyqi S., Bajraktari G., Henein M.Y. Percutaneous Coronary Intervention Is Not Superior to Optimal Medical Therapy in Chronic Coronary Syndrome: A Meta-Analysis. J. Clin. Med. 2023:12:1395. doi: 10.3390/jcm12041395Bytyçi I., Morina D., Bytyqi S., Bajraktari G., Henein M.Y. Percutaneous Coronary Intervention Is Not Superior to Optimal Medical Therapy in Chronic Coronary Syndrome: A Meta-Analysis. J. Clin. Med. 2023:12:1395. doi: 10.3390/jcm12041395Madhavan M.V., Kirtane A.J., Redfors B., Généreux P., Ben-Yehuda O., Palmerini T., Benedetto U., Biondi-Zoccai G., Smits P.C., von Birgelen C., Mehran R., McAndrew T., Serruys P.W., Leon M.B., Pocock S.J., Stone G.W. Stent-Related Adverse Events > 1 Year After Percutaneous Coronary Intervention. JACC. 2020:75(6):590-604. doi: 10.1016/j.jacc.2019.11.058Madhavan M.V., Kirtane A.J., Redfors B., Généreux P., Ben-Yehuda O., Palmerini T., Benedetto U., Biondi-Zoccai G., Smits P.C., von Birgelen C., Mehran R., McAndrew T., Serruys P.W., Leon M.B., Pocock S.J., Stone G.W. Stent-Related Adverse Events > 1 Year After Percutaneous Coronary Intervention. JACC. 2020:75(6):590-604. doi: 10.1016/j.jacc.2019.11.058Cassese S., Byrne R.A., Tada T., Pinieck S., Joner M., Ibrahim T., King L.A., Fusaro M., Laugwitz K.-L., Kastrati A. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart 2014;100:153-159. doi: 10.1136/heartjnl-2013-304933Cassese S., Byrne R.A., Tada T., Pinieck S., Joner M., Ibrahim T., King L.A., Fusaro M., Laugwitz K.-L., Kastrati A. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart 2014;100:153-159. doi: 10.1136/heartjnl-2013-304933Wan Y-D., Wang D-Y., Deng W-Q., Lai S-J., Wang X. Bioresorbable scaffolds vs. drug-eluting stents on short- and mid-term target lesion outcomes in patients after PCI: A systematic review and meta-analysis. Front Cardiovasc Med. 2022 9:949494. doi: 10.3389/fcvm.2022.949494Wan Y-D., Wang D-Y., Deng W-Q., Lai S-J., Wang X. Bioresorbable scaffolds vs. drug-eluting stents on short- and mid-term target lesion outcomes in patients after PCI: A systematic review and meta-analysis. Front Cardiovasc Med. 2022 9:949494. doi: 10.3389/fcvm.2022.949494Klein L.W., Nathan S., Maehara A., Messenger J., Mintz G.S., Ali Z.A., Rymer J., Sandoval Y., Al-Azizi K., Mehran R., Rao S.V., Lotfi A. SCAI Expert Consensus Statement on Management of In-Stent Restenosis and Stent Thrombosis. Journal of the Society for Cardiovascular Angiography & Interventions 2023:100971. doi: 10.1016/j.jscai.2023.100971Klein L.W., Nathan S., Maehara A., Messenger J., Mintz G.S., Ali Z.A., Rymer J., Sandoval Y., Al-Azizi K., Mehran R., Rao S.V., Lotfi A. SCAI Expert Consensus Statement on Management of In-Stent Restenosis and Stent Thrombosis. Journal of the Society for Cardiovascular Angiography & Interventions 2023:100971. doi: 10.1016/j.jscai.2023.100971Clare J., Ganly J., Bursill C.A., Sumer H., Kingshott P., de Haan J.B. The Mechanisms of Restenosis and Relevance to Next Generation Stent Design. Biomolecules. 2022:12:430. doi: 10.3390/biom12030430Clare J., Ganly J., Bursill C.A., Sumer H., Kingshott P., de Haan J.B. The Mechanisms of Restenosis and Relevance to Next Generation Stent Design. Biomolecules. 2022:12:430. doi: 10.3390/biom12030430Mehran R., Dangas G., Abizaid A.S., Mintz G.S., Lansky A.J., Satler L.F., Pichard A.D., Kent K.M., Stone G.W., Leon M.B. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999:100(18):1872-1878. doi: 10.1161/01.cir.100.18.1872Mehran R., Dangas G., Abizaid A.S., Mintz G.S., Lansky A.J., Satler L.F., Pichard A.D., Kent K.M., Stone G.W., Leon M.B. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999:100(18):1872-1878. doi: 10.1161/01.cir.100.18.1872Shlofmitz E., Iantorno M., Waksman R. Restenosis of drug-eluting stents: a new classification system based on disease mechanism to guide treatment and stateof-the-art review. Circ Cardiovasc Interv. 2019:12(8): e007023. doi: 10.1161/CIRCINTERVENTIONS.118.007023Shlofmitz E., Iantorno M., Waksman R. Restenosis of drug-eluting stents: a new classification system based on disease mechanism to guide treatment and stateof-the-art review. Circ Cardiovasc Interv. 2019:12(8): e007023. doi: 10.1161/CIRCINTERVENTIONS.118.007023Kang S.J., Mintz G.S., Park D.W., Lee S.W., Kim Y.H., Lee C.W., Han K.H., Kim J.J., Park S.W., Park S.J. Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis. Am J Cardiol. 2010:106(11):1561-1565. doi: 10.1016/j.amjcard.2010.07.031Kang S.J., Mintz G.S., Park D.W., Lee S.W., Kim Y.H., Lee C.W., Han K.H., Kim J.J., Park S.W., Park S.J. Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis. Am J Cardiol. 2010:106(11):1561-1565. doi: 10.1016/j.amjcard.2010.07.031Gonzalo N., Serruys P.W., Okamura T., van Beusekom H.M., Garcia-Garcia H.M., van Soest G., van der Giessen W., Regar E. Optical coherence tomography patterns of stent restenosis. Am Heart J. 2009:158(2):284-293. doi: 10.1016/j.ahj.2009.06.004Gonzalo N., Serruys P.W., Okamura T., van Beusekom H.M., Garcia-Garcia H.M., van Soest G., van der Giessen W., Regar E. Optical coherence tomography patterns of stent restenosis. Am Heart J. 2009:158(2):284-293. doi: 10.1016/j.ahj.2009.06.004Ali Z.A., Roleder T., Narula J., Mohanty B.D., Baber U., Kovacic J.C., Mintz G.S., Otsuka F., Pan S., Virmani R., Sharma S.K., Moreno P., Kini A.S. Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents. Circ Cardiovasc Interv. 2013:6(5):507-517. doi: 10.1161/CIRCINTERVENTIONS.112.000248Ali Z.A., Roleder T., Narula J., Mohanty B.D., Baber U., Kovacic J.C., Mintz G.S., Otsuka F., Pan S., Virmani R., Sharma S.K., Moreno P., Kini A.S. Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents. Circ Cardiovasc Interv. 2013:6(5):507-517. doi: 10.1161/CIRCINTERVENTIONS.112.000248Her A.-Y., Shin E.-S. Current Management of In-Stent Restenosis. Korean Circ J. 2018:48(5):337-349. doi: 10.4070/kcj.2018.0103Her A.-Y., Shin E.-S. Current Management of In-Stent Restenosis. Korean Circ J. 2018:48(5):337-349. doi: 10.4070/kcj.2018.0103Pleva L., Kukla P., Hlinomaz O. Treatment of coronary in-stent restenosis: a systematic review. Journal of Geriatric Cardiology 2018:15:173-184. doi: 10.11909/j.issn.1671-5411.2018.02.007Pleva L., Kukla P., Hlinomaz O. Treatment of coronary in-stent restenosis: a systematic review. Journal of Geriatric Cardiology 2018:15:173-184. doi: 10.11909/j.issn.1671-5411.2018.02.007Bajeu I.-T., Niculescu A.-G., Scafa-Udris te A., Andronescu E. Intrastent Restenosis: A Comprehensive Review. Int J Mol Sci 2024:25:1715. doi: 10.3390/ijms25031715Bajeu I.-T., Niculescu A.-G., Scafa-Udris te A., Andronescu E. Intrastent Restenosis: A Comprehensive Review. Int J Mol Sci 2024:25:1715. doi: 10.3390/ijms25031715Ashrafian H., Darzi A., Athanasiou T. Auto-bionics – a new paradigm in Regenerative Medicine and Surgery. Regen Med. 2010:5(2):279-288. doi: 10.2217/rme.10.2Ashrafian H., Darzi A., Athanasiou T. Auto-bionics – a new paradigm in Regenerative Medicine and Surgery. Regen Med. 2010:5(2):279-288. doi: 10.2217/rme.10.2Фролов А.В. Морфофункциональная система кондуит-артерия: клинико-патофизиологическая концепция как основа эффективности аутоартериального коронарного шунтирования: дисс. … док. мед. наук. Кемерово, 2023. 388 с.Frolov A.V. Morfofunkcional'naja sistema konduit-arterija: kliniko-patofiziologicheskaja koncepcija kak osnova jeffektivnosti autoarterial'nogo koronarnogo shuntirovanija: diss. … dok. med. nauk. Kemerovo, 2023. (In Russian)Gori T. Vascular Wall Reactions to Coronary Stents – Clinical Implications for Stent Failure. Life. 2021:11:63. doi: 10.3390/life11010063Gori T. Vascular Wall Reactions to Coronary Stents – Clinical Implications for Stent Failure. Life. 2021:11:63. doi: 10.3390/life11010063Hu W., Jiang J. Hypersensitivity and in-stent restenosis in coronary stent materials. Front. Bioeng Biotechnol. 2022:10:1003322. doi: 10.3389/fbioe.2022.1003322Hu W., Jiang J. Hypersensitivity and in-stent restenosis in coronary stent materials. Front. Bioeng Biotechnol. 2022:10:1003322. doi: 10.3389/fbioe.2022.1003322Brami P., Fischer Q., Pham V., Seret G., Varenne O., Picard F. Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents. J Clin Med. 2023:12:6711. doi: 10.3390/jcm12216711Brami P., Fischer Q., Pham V., Seret G., Varenne O., Picard F. Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents. J Clin Med. 2023:12:6711. doi: 10.3390/jcm12216711Nicolas J., Pivato C.A., Chiarito M., Beerkens F., Cao D., Mehran R. Evolution of drug-eluting coronary stents: a backand-forth journey from the bench to bedside. Cardiovascular Research. 2023:119:631-646. doi: 10.1093/cvr/cvac105Nicolas J., Pivato C.A., Chiarito M., Beerkens F., Cao D., Mehran R. Evolution of drug-eluting coronary stents: a backand-forth journey from the bench to bedside. Cardiovascular Research. 2023:119:631-646. doi: 10.1093/cvr/cvac105Chioncel V., Andrei C.L., Brezeanu R., Sinescu C., Avram A., Tatu A.L. Some Perspectives on Hypersensitivity to Coronary Stents. International Journal of General Medicine 2021:14:4327-4336. doi: 10.2147/IJGM.S326679Chioncel V., Andrei C.L., Brezeanu R., Sinescu C., Avram A., Tatu A.L. Some Perspectives on Hypersensitivity to Coronary Stents. International Journal of General Medicine 2021:14:4327-4336. doi: 10.2147/IJGM.S326679Cook S., Ladich E., Nakazawa G., Eshtehardi P., Neidhart M., Vogel R., Togni M., Wenaweser P., Billinger M., Seiler C., Gay S., Meier B., Pichler W.J., Jüni P., Virmani R., Windecker S. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation. 2009:120(5):391-399. doi:10.1161/CIRCULATIONAHA.109.Cook S., Ladich E., Nakazawa G., Eshtehardi P., Neidhart M., Vogel R., Togni M., Wenaweser P., Billinger M., Seiler C., Gay S., Meier B., Pichler W.J., Jüni P., Virmani R., Windecker S. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation. 2009:120(5):391-399. doi:10.1161/CIRCULATIONAHA.109.Otsuka F., Yahagi K., Ladich E., Kutys R., Alexander R., Fowler D., Virmani R., Joner M. Hypersensitivity reaction in the US food and drug administration-approved second-generation drug-eluting stents: Histopathological assessment with ex vivo optical coherence tomography. Circulation. 2015:131(3):322-324. doi: 10.1161/CIRCULATIONAHA.114.012658Otsuka F., Yahagi K., Ladich E., Kutys R., Alexander R., Fowler D., Virmani R., Joner M. Hypersensitivity reaction in the US food and drug administration-approved second-generation drug-eluting stents: Histopathological assessment with ex vivo optical coherence tomography. Circulation. 2015:131(3):322-324. doi: 10.1161/CIRCULATIONAHA.114.012658Strohbach A., Busch R. Polymers for Cardiovascular Stent Coatings. International Journal of Polymer Science. 2015:782653. doi: 10.1155/2015/782653Strohbach A., Busch R. Polymers for Cardiovascular Stent Coatings. International Journal of Polymer Science. 2015:782653. doi: 10.1155/2015/782653Kozlik M., Harpula J., Chuchra P.J., Nowak M., Wojakowski W., Gasior P. Drug-Eluting Stents: Technical and Clinical Progress. Biomimetics. 2023:8:72. doi: 10.3390/biomimetics8010072Kozlik M., Harpula J., Chuchra P.J., Nowak M., Wojakowski W., Gasior P. Drug-Eluting Stents: Technical and Clinical Progress. Biomimetics. 2023:8:72. doi: 10.3390/biomimetics8010072Marei I., Ahmetaj-Shala B., Triggle C.R. Biofunctionalization of cardiovascular stents to induce endothelialization: Implications for instent thrombosis in diabetes. Front Pharmacol. 2022:13:982185. doi: 10.3389/fphar.2022.982185Marei I., Ahmetaj-Shala B., Triggle C.R. Biofunctionalization of cardiovascular stents to induce endothelialization: Implications for instent thrombosis in diabetes. Front Pharmacol. 2022:13:982185. doi: 10.3389/fphar.2022.982185Daoud F.C., Catargi B., Karjalainen P.P., Gerbaud E. Five-Year Efficacy and Safety of TiNO-Coated Stents Versus Drug-Eluting Stents in Acute Coronary Syndrome: A Meta-Analysis. J Clin Med. 2023:6;12(21):6952. doi: 10.3390/jcm12216952Daoud F.C., Catargi B., Karjalainen P.P., Gerbaud E. Five-Year Efficacy and Safety of TiNO-Coated Stents Versus Drug-Eluting Stents in Acute Coronary Syndrome: A Meta-Analysis. J Clin Med. 2023:6;12(21):6952. doi: 10.3390/jcm12216952Saqib M., Kuzmin O.S., Kraskiewicz H., Wasyluk L., Cuniberti G., Ficai A.A., Pichugin V.F., Opitz J., Beshchasna N. Evaluation of in Vitro Corrosion Behavior of Titanium Oxynitride Coated Stainless Steel Stents. IEEE Access, 2021:9:59766-59782. doi: 10.1109/ACCESS.2021.3072597Saqib M., Kuzmin O.S., Kraskiewicz H., Wasyluk L., Cuniberti G., Ficai A.A., Pichugin V.F., Opitz J., Beshchasna N. Evaluation of in Vitro Corrosion Behavior of Titanium Oxynitride Coated Stainless Steel Stents. IEEE Access, 2021:9:59766-59782. doi: 10.1109/ACCESS.2021.3072597Lee D.-H., de la Torre Hernandez J.M. The Newest Generation of Drug-eluting Stents and Beyond. European Cardiology Review 2018:13(1):54-9. doi: 10.15420/ecr.2018:8:2Lee D.-H., de la Torre Hernandez J.M. The Newest Generation of Drug-eluting Stents and Beyond. European Cardiology Review 2018:13(1):54-9. doi: 10.15420/ecr.2018:8:2Shishkova D., Markova V., Sinitsky M., Tsepokina A., Frolov A., Zagorodnikov N., Bogdanov L., Kutikhin A. Co-Culture of Primary Human Coronary Artery and Internal Thoracic Artery Endothelial Cells Results in Mutually Beneficial Paracrine Interactions. Int J Mol Sci. 2020:21(21):8032. doi: 10.3390/ijms21218032Shishkova D., Markova V., Sinitsky M., Tsepokina A., Frolov A., Zagorodnikov N., Bogdanov L., Kutikhin A. Co-Culture of Primary Human Coronary Artery and Internal Thoracic Artery Endothelial Cells Results in Mutually Beneficial Paracrine Interactions. Int J Mol Sci. 2020:21(21):8032. doi: 10.3390/ijms21218032Spadaccio C., Antoniades C., Nenna A., Chung C., Will R., Chello M., Gaudino M.F.L. Preventing treatment failures in coronary artery disease: what can we learn from the biology of in-stent restenosis, vein graft failure, and internal thoracic arteries? Cardiovasc Res. 2020:116 (3):505-519. doi: 10.1093/cvr/cvz214Spadaccio C., Antoniades C., Nenna A., Chung C., Will R., Chello M., Gaudino M.F.L. Preventing treatment failures in coronary artery disease: what can we learn from the biology of in-stent restenosis, vein graft failure, and internal thoracic arteries? Cardiovasc Res. 2020:116 (3):505-519. doi: 10.1093/cvr/cvz214Peng X., Qu W., Jia Y., Wang Y., Yu B., Tian J. Bioresorbable Scaffolds: Contemporary Status and Future Directions. Front Cardiovasc Med. 2020:30(7):589571. doi: 10.3389/fcvm.2020.589571Peng X., Qu W., Jia Y., Wang Y., Yu B., Tian J. Bioresorbable Scaffolds: Contemporary Status and Future Directions. Front Cardiovasc Med. 2020:30(7):589571. doi: 10.3389/fcvm.2020.589571Forrestal B., Case B.C., Yerasi C., Musallam A., Chezar-Azerrad C., Waksman R. Bioresorbable Scaffolds: Current Technology and Future Perspectives. Rambam Maimonides Med J. 2020:29:11(2):e0016. doi: 10.5041/RMMJ.10402Forrestal B., Case B.C., Yerasi C., Musallam A., Chezar-Azerrad C., Waksman R. Bioresorbable Scaffolds: Current Technology and Future Perspectives. Rambam Maimonides Med J. 2020:29:11(2):e0016. doi: 10.5041/RMMJ.10402Stone G.W., Kereiakes D.J., Gori T., Metzger D.C., Stein B., Erickson M., Torzewski J., Kabour A., Piegari G., Cavendish J., Bertolet B., Stockelman K.A., West N.E.J., Ben-Yehuda O., Choi J.W., Marx S.O., Spertus J.A., Ellis S.G.; ABSORB IV Investigators. 5-Year Outcomes After Bioresorbable Coronary Scaffolds Implanted With Improved Technique. J Am Coll Cardiol. 2023:18:82(3):183-195. doi: 10.1016/j.jacc.2023.05.003Stone G.W., Kereiakes D.J., Gori T., Metzger D.C., Stein B., Erickson M., Torzewski J., Kabour A., Piegari G., Cavendish J., Bertolet B., Stockelman K.A., West N.E.J., Ben-Yehuda O., Choi J.W., Marx S.O., Spertus J.A., Ellis S.G.; ABSORB IV Investigators. 5-Year Outcomes After Bioresorbable Coronary Scaffolds Implanted With Improved Technique. J Am Coll Cardiol. 2023:18:82(3):183-195. doi: 10.1016/j.jacc.2023.05.003Shishatskaya E.I., Menzyanova N.G., Shumilova A.A. The effect of the chemical composition and structure of polymer films made from resorbable polyhydroxyalkanoates on blood cell response. Int J Biol Macromol. 2019:1(141):765-775. doi: 10.1016/j.ijbiomac.2019.09.015Shishatskaya E.I., Menzyanova N.G., Shumilova A.A. The effect of the chemical composition and structure of polymer films made from resorbable polyhydroxyalkanoates on blood cell response. Int J Biol Macromol. 2019:1(141):765-775. doi: 10.1016/j.ijbiomac.2019.09.015Barungi S., Hernández-Camarero P., Moreno-Terribas G., Villalba-Montoro R., Marchal J.A., López-Ruiz E., Perán M. Clinical implications of inflammation in atheroma formation and novel therapies in cardiovascular diseases. Front Cell Dev Biol. 2023:16(11):1148768. doi: 10.3389/fcell.2023.1148768Barungi S., Hernández-Camarero P., Moreno-Terribas G., Villalba-Montoro R., Marchal J.A., López-Ruiz E., Perán M. Clinical implications of inflammation in atheroma formation and novel therapies in cardiovascular diseases. Front Cell Dev Biol. 2023:16(11):1148768. doi: 10.3389/fcell.2023.1148768Aziz K.S., Saxton G.M., inventors; Atherolysis Medical, Inc., assignee. Atherosclerotic plaque dissolution composition. United States patent US 13/087,520. 2011 Apr 15Aziz K.S., Saxton G.M., inventors; Atherolysis Medical, Inc., assignee. Atherosclerotic plaque dissolution composition. United States patent US 13/087,520. 2011 Apr 15Аprotosoaie A.C., Costache A.-D., Costache I.-I. Therapeutic Strategies and Chemoprevention of Atherosclerosis: What Do We Know and Where Do We Go? Pharmaceutics. 2022:14:722. doi: 10.3390/ pharmaceutics14040722Аprotosoaie A.C., Costache A.-D., Costache I.-I. Therapeutic Strategies and Chemoprevention of Atherosclerosis: What Do We Know and Where Do We Go? Pharmaceutics. 2022:14:722. doi: 10.3390/ pharmaceutics14040722Wang S., Chen C.Y., Rzasa J.R., Tsao C.Y., Li J., Van Arsdale E., Kim E., Zakaria F.R., Payne G.F., Bentley W.E. Redox-enabled electronic interrogation and feedback control of hierarchical and networked biological systems. Nat Commun. 2023:14(1):8514. doi: 10.1038/s41467-023-44223-wWang S., Chen C.Y., Rzasa J.R., Tsao C.Y., Li J., Van Arsdale E., Kim E., Zakaria F.R., Payne G.F., Bentley W.E. Redox-enabled electronic interrogation and feedback control of hierarchical and networked biological systems. Nat Commun. 2023:14(1):8514. doi: 10.1038/s41467-023-44223-wMazzotti G., Hartmann D., Booth M.J. Precise, Orthogonal Remote-Control of Cell-Free Systems Using Photocaged Nucleic Acids. J Am Chem Soc. 2023:145(17):9481-9487. doi: 10.1021/jacs.3c01238Mazzotti G., Hartmann D., Booth M.J. Precise, Orthogonal Remote-Control of Cell-Free Systems Using Photocaged Nucleic Acids. J Am Chem Soc. 2023:145(17):9481-9487. doi: 10.1021/jacs.3c01238Mundell J.W., Brier M.I., Orloff E., Stanley S.A., Dordick J.S. Alternating magnetic fields drive stimulation of gene expression via generation of reactive oxygen species. iScience. 2024:27(3):109186. doi: 10.1016/j.isci.2024.109186Mundell J.W., Brier M.I., Orloff E., Stanley S.A., Dordick J.S. Alternating magnetic fields drive stimulation of gene expression via generation of reactive oxygen species. iScience. 2024:27(3):109186. doi: 10.1016/j.isci.2024.109186Mosabbir A.A., Truong K. Genetically Encoded Circuit for Remote Regulation of Cell Migration by Magnetic Fields. ACS Synth Biol. 2018:7(2):718-726. doi: 10.1021/acssynbio.7b00415Mosabbir A.A., Truong K. Genetically Encoded Circuit for Remote Regulation of Cell Migration by Magnetic Fields. ACS Synth Biol. 2018:7(2):718-726. doi: 10.1021/acssynbio.7b00415Wang L., Li X., Li T., Liu L., Wang H., Wang C. Novel application of drug-coated balloons in coronary heart disease: A narrative review. Front Cardiovasc Med. 2023:10:1055274. doi: 10.3389/fcvm.2023.1055274Wang L., Li X., Li T., Liu L., Wang H., Wang C. Novel application of drug-coated balloons in coronary heart disease: A narrative review. Front Cardiovasc Med. 2023:10:1055274. doi: 10.3389/fcvm.2023.1055274Rivero-Santana B., Jurado-Roman A., Galeote G., Jimenez-Valero S., Gonzalvez A., Tebar D., Moreno R. Drug-Eluting Balloons in Calcified Coronary Lesions: A Meta-Analysis of Clinical and Angiographic Outcomes. J Clin Med. 2024:13(10):2779. doi: 10.3390/jcm13102779Rivero-Santana B., Jurado-Roman A., Galeote G., Jimenez-Valero S., Gonzalvez A., Tebar D., Moreno R. Drug-Eluting Balloons in Calcified Coronary Lesions: A Meta-Analysis of Clinical and Angiographic Outcomes. J Clin Med. 2024:13(10):2779. doi: 10.3390/jcm13102779

The authors declare that there are no conflicts of interest present.